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Résumé en
anglais
Classically, Toxoplasma infection is associated with high levels of specific IgM
antibody and a rise in specific IgG levels 1 to 3 weeks later. Atypical IgG
seroconversion, without IgM detection or with transient IgM levels, has been
described during serologic follow-up of seronegative pregnant women and raises
difficulties in interpreting the results. To evaluate the frequency and the
characteristics of these atypical cases of seroconversion, an investigation was
conducted within the French National Reference Center for Toxoplasmosis, from
which 26 cases collected from 12 laboratories belonging to the network were
identified. The aim of this work was to retrospectively analyze the results of serologic
testing, the treatments administered, and the results of prenatal and postnatal
follow-up for these women. In each case, IgG antibodies were detected using both
screening and confirmatory tests. IgM antibodies were not detected in 15 cases, and
the levels were equivocal or low-positive in 11 cases. The IgG avidity results were
low in 16 cases and high in one case. Most of the pregnant women (22/26) were
treated with spiramycin from the time that IgG antibodies appeared until delivery.
Amniotic fluid was analyzed for Toxoplasma gondii DNA by PCR in 11/26 cases, and
the results were negative in all cases. Congenital toxoplasmosis was ruled out in
12/26 newborns. There was no abnormality observed at birth for 10 newborns and no
information available for 4 newborns. In conclusion, when the interpretation of
serological results is so difficult, it seems cautious to initiate treatment by spiramycin
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